ANN ARBOR, MI — November 20, 2025 — MELD Health, Inc., a Health-technology startup reinventing how chronic pain patients communicate with clinicians and how clinicians manage chronic pain, today announced a series of foundational milestones marking its official launch.
MELD Health, Inc. formally incorporated as a C-Corporation in Q3 2025 and celebrated its official bell-ringing ceremony on November 20, 2025 at the University of Michigan Innovation Partnerships. The ceremony commemorated the company’s transition from early development efforts into a fully established venture preparing for operational readiness.
The company will begin operations in the first half of 2026 at the University of Michigan’s North Campus Research Complex (NCRC) in Ann Arbor, where it will continue to advance next-generation technologies for chronic pain care.
Co-founded by Dr. Alexandre DaSilva and Dr. David Hanna, MELD Health, Inc. brings together world-class expertise in neuroscience-driven innovation and clinical-technology commercialization.
- DaSilva, internationally recognized for his pioneering work at the intersection of migraine/pain neuroscience and digital Health, is an Endowed Professor at the University of Michigan and Director of the H.O.P.E. (Headache & Orofacial Pain Effort) Laboratory. He leads a multidisciplinary team creating advanced solutions for chronic pain disorders including migraine, temporomandibular disorders (TMD), and fibromyalgia.
- Hanna, a life science industry veteran with more than 20 years commercially transitioning clinical genomics and clinical data-analysis technologies to market, serves as President and CEO.
MELD Health, Inc. has signed an exclusive licensing agreement with the University of Michigan to commercialize intellectual property originating from the H.O.P.E. Lab. The company’s formation builds on groundwork innovations supported by the University of Michigan’s BOLD Challenges initiative and the National Institutes of Health Blueprint program.
To support its incorporation and licensing activities, MELD Health, Inc. has retained Gunderson Dettmer, a leading global law firm specializing in emerging-company representation, through its Ann Arbor office as the company’s primary corporate counsel.
“With our incorporation complete, our license secured, and our launch underway, MELD Health, Inc. is positioned to transform how chronic pain is understood, communicated, and managed,” said the company’s founders. “We look forward to advancing technologies that meaningfully improve the lives of clinicians and patients.”
